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Salp15, an Ixodes scapularis Salivary Protein,
Inhibits CD4 T Cell Activation
Kuthejlova, 1998), reduce homocytotrophic and circulat-
ing antibody titers (Wikel and Bergman, 1997), repress
production of cytokines, such as interleukin-2 (IL-2) and
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1992; Schoeler et al., 1999), and inhibit the proliferationMercedes Rinco´n,3 Fred S. Kantor,2
and Erol Fikrig1,5 of T lymphocytes (Ramachandra and Wikel, 1992; Uri-
oste et al., 1994). Immunosuppression of the host by1Sections of Rheumatology and
2 Clinical Allergy and Immunology tick saliva may result in more efficient transmission of
several tick-borne pathogens (Wikel, 1999; Zeidner etDepartment of Internal Medicine
Yale University School of Medicine al., 1996). Recently, a protein-associated IL-2 binding
activity (Gillespie et al., 2001) has been described in tickNew Haven, Connecticut 06520
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Several animal species acquire resistance to ticksUniversity of Vermont
Burlington, Vermont 05405 after repeated exposure to the vector, a phenomenon
known as tick immunity (Brown and Askenase, 1985;4 Department of Biology
University of North Carolina Trager, 1939; Wang and Nuttall, 1999; Wikel, 1996). Al-
tered cytokine expression levels (Schorderet and Bros-Charlotte, North Carolina 28223
sard, 1994), acute basophil hypersensitivity at the site
of the tick bite (Askenase et al., 1982), and circulating
antibodies to several tick salivary gland proteins are allSummary
thought to contribute to this phenomenon (Girardin and
Brossard, 1989; Worms et al., 1988). Tick-immunity re-Tick saliva has pleiotropic properties that facilitate
persistence of the arthropod upon the host. We now sults in impairment of attachment of adult and nymphal
ticks, lower postengorgement weights, and increaseddescribe a feeding-inducible protein in Ixodes scapu-
laris saliva, Salp15, that inhibits CD4 T cell activation. levels of mortality. Therefore, it is not surprising that
tick saliva contains components that modulate the hostThe mechanism involves the repression of calcium
fluxes triggered by TCR ligation and results in lower immune response. Assessing the components in tick
saliva that are responsible for immunosuppression mayproduction of interleukin-2. Salp15 also inhibits the
development of CD4 T cell-mediated immune re- lead to a further understanding of vector-pathogen-host
interactions. We here report the characterization of a 15sponses in vivo, demonstrating the functional impor-
tance of this protein. Salp15 provides a molecular ba- kDa tick salivary protein that inhibits the activation of
CD4 T cells through the repression of calcium signalssis for understanding the immunosuppressive activity
of I. scapularis saliva and vector-host interactions. triggered by TCR engagement.
Introduction Results
Ixodes scapularis ticks are the vector for several medi- Salp15 Inhibits CD4 T Cell Proliferation
cally important pathogens, including the causative At least 14 antigens in I. scapularis saliva that are recog-
agents of Lyme disease and human granulocytic ehr- nized by the mammalian host during tick exposure were
lichiosis (Burgdorfer et al., 1982; Chen et al., 1994). Tick- identified by probing an I. scapularis cDNA expression
host interactions have been the subject of extensive library with sera from rabbits that had been fed upon
investigation (Allen, 1989; Wikel and Bergman, 1997). I. by ticks (Das et al., 2001). The sequence analysis of one
scapularis requires a 5 to 7 day attachment period on the of those antigens, Salp15, revealed weak similarities
mammalian host in order to feed to repletion (Binnington with two motifs of Inhibin A, a member of the TGF
and Kemp, 1980). The long period of tick engorgement super-family (FingerPRINTScan search tool at http://
allows the host to generate immune responses directed bioinf.man.ac.uk/cgi-bin/dbbrowser/fingerPRINTScan/
toward secreted components of the vector. In turn, I. muppet/FPScan.cgi) (Mason et al., 1985) (Figures 1A
scapularis attempts to modulate these responses in or- and 1B; E value: 1.9 103 ). Like tick saliva, TGF inhibits
der to effectively attach to and feed upon its host (Bin- the production of cytokines, such as IL-2, and the prolif-
nington and Kemp, 1980; Kopecky et al., 1999; Rama- eration of T cells (Wahl, 1994), suggesting that Salp15
chandra and Wikel, 1992; Urioste et al., 1994; Wikel, may have immune-modulatory properties. Salp15 was
1999). expressed and purified in a Drosophila cell line-based
Tick salivary proteins that enter the host during feed- system for use in functional assays (Figure 1C, lane
ing have multiple effects, including the ability to inhibit 1). Tick-immune rabbit sera reacted with Salp15 in a
the complement cascade (Ribeiro, 1987, 1995; Valen- Western blot assay (Figure 1B, lane 2), confirming that
zuela et al., 2000), impair NK cell function (Kopecky and antibodies against tick saliva recognize the recombinant
protein. Recombinant Salp15 migrated at 24–27 kDa in
denaturing SDS-PAGE (Figure 1B), due to posttransla-5 Correspondence: erol.fikrig@yale.edu
6 These authors contributed equally to this work. tional modifications, consistent with other I. scapularis
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Figure 1. Characterization of Salp15
(A) Nucleotide and amino acid sequence of Salp15. The putative 21 amino acid signal sequence is highlighted in gray. The amino acid
sequences highlighted in black represent regions that are similar to Inhibin A fingerprints.
(B) Comparison of motifs 4 and 7 of the rat Inhibin A molecule and Salp15. Identical residues are linked with (|); similar residues are marked
with (:). The * indicates the end of the sequence.
(C) Recombinant Salp15 produced in Drosophila cells stained with Coomassie blue (1), Western blot analysis of the recombinant protein
probed with tick-immune rabbit sera (2), and whole saliva probed with anti-Salp15 antibodies produced in rabbits (3).
(D) Immunohistochemistry to detect Salp15 at the site of tick attachment. Skin biopsies of tick-infested mice were probed with Salp15 antisera
(4) or normal rabbit sera (2) 2 days after tick detachment. Controls included the skin of naive mice (1 and 3).
proteins (Das et al., 2000). The glycosylation of the pro- 24, and 42 hr of activation (Figure 2B). Salp15 activity
was not due to induction of TGF during the activationtein was confirmed by staining with periodate-Schiff’s
reagent (data not shown). Rabbit antisera raised against process (data not shown). We then assessed the ability
of Salp15 to bind CD4 T cells. Purified CD4 T cellsthe recombinant protein recognized Salp15 in whole
tick saliva (Figure 1C, lane 3). Some crossreaction was were incubated with fluorescein-labeled Salp15 and an-
alyzed by flow cytometry. Increasing concentrations ofobserved with proteins in the range of 50–55 kDa. Sera
from naive rabbits did not react with proteins in tick Salp15FITC bound to CD4 T cells (Figure 2C). We also
tested the binding capacity of Salp15 in a microtitersaliva (data not shown). Salp15 could be readily de-
tected in skin biopsies of mice 2 days after tick detach- assay. Increasing concentrations of Salp15 bound to
the membrane preparations (Figure 2D). The bindingment (Figure 1D), indicating that the protein is present
in vivo at the site of natural inoculation. capacity of Salp15 was abolished when the membrane
preparations were preincubated with trypsin (Figure 2D),We examined the effect of Salp15 on the proliferation
of purified CD4 T cells in response to anti-CD3 and suggesting that Salp15 is binding to a protein compo-
nent on the surface of CD4 T cells.anti-CD28 monoclonal antibodies (mAb). Proliferative
responses were impaired by Salp15 in a dose-depen-
dent manner (Figure 2A). To rule out a cytotoxic effect Salp15 Inhibits IL-2 Production and CD25
Expression in CD4 T Cellsof Salp15 on CD4 T cells, their viability was tested by
trypan blue exclusion at different time points of activa- We then examined the effect of Salp15 on IL-2 produc-
tion by CD4 T cells activated with anti-CD3 and anti-tion. No differences were observed in cell viability be-
tween control and Salp15-treated CD4 T cells at 12, CD28 mAbs in the presence of Salp15. The level of IL-2
Immunosuppression Mediated by Salp15
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Figure 2. Salp15 Inhibits CD4 T Cell Prolif-
eration
(A) 106 naive CD4 T cells per ml were acti-
vated with anti-CD3/CD28 mAbs for 78 hr in
the presence of different concentrations of
Salp15. The cells were pulsed with 1 Ci
[3 H]thymidine for the last 18 hr of the assay.
(B) The viability of CD4 T cells (106 cells/ml)
activated with anti-CD3/CD28 mAbs in the
presence of Salp15 (50 g/ml) (open squares)
was analyzed by trypan blue exclusion at dif-
ferent times of activation. Closed squares
represent control studies without Salp15.
(C) Purified CD4 T cells were incubated with
Salp15FITC (4, red line; 12, green line; and 30
g per 106 cells, blue line). The cells were
then analyzed by flow cytometry.
(D) Membrane fractions were purified from
CD4 T cells and used in a microtiter assay
to determine binding of Salp15 (closed
squares). Preincubation of the membrane
fractions with trypsin resulted in elimination
of Salp15 binding (open squares). The results
are representative of at least three indepen-
dent experiments.
produced by CD4 T cells stimulated in the presence are undergoing activation provides strong signals that
permit the activation process to continue and the cellsof Salp15 was lower (Figure 3A) than in the control un-
treated cells. The inhibitory effect of Salp15 on CD4 T to enter the proliferative cycle. We therefore tested
whether the addition of Salp15 would have the samecell IL-2 production was dose dependent (Figure 3A)
and evident throughout the activation period (Figure 3B). effect on CD4 T cell activation when added at later
time points, once IL-2 is already available to the cell.The inhibition of IL-2 production was also observed at
the mRNA level in purified CD4 T cells that had been IL-2 production was decreased when the cells had been
activated with anti-CD3 and anti-CD28 for 12 hr prior toactivated for 16 hr (Figure 3C). The inhibition of IL-2
production was completely abolished by the addition of the addition of Salp15 (Figure 4C). In contrast, the levels
of IL-2 produced by CD4 T cells incubated with anti-Salp15 antisera during the activation period (Figure 3D).
Furthermore, saliva-mediated inhibition of IL-2 produc- CD3 and anti-CD28 for 20 hr before the addition of
Salp15 were less affected (Figure 4C), and no effect wastion by CD4 T cells was reversed by Salp15 antisera
(Figure 3D), suggesting that the proteins recognized by found on IL-2 production when Salp15 was added at 40
hr of activation (Figure 4C). These data indicated that thethe antibodies are the primary inhibitors of IL-2 produc-
tion by CD4 T cells. inhibition of CD4 T cell activation by Salp15 occurred
in the initial period of activation. Overall, our resultsWe then assessed whether the inhibitory effect of
Salp15 on IL-2 production by CD4 T cells influenced indicated that Salp15 inhibited CD4 T cell activation
by inhibiting IL-2 production.CD25 expression. Salp15 caused a substantial reduction
in the levels of CD25 expression at 40 hr of activation
(Figure 3E). The reduction was evident as soon as 12 hr Salp15 Inhibits Ca2 Mobilization after TCR Ligation
Several regulatory elements have been identified withinand persisted throughout the activation period (data
not shown). These data show that Salp15 specifically the proximal IL-2 promoter, including the activator pro-
tein (AP)-1, nuclear factor of activated T cells (NF-AT),inhibits IL-2 production and CD25 expression by CD4
T cells activated by anti-CD3 and anti-CD28 mAbs. and nuclear factor  B (NF-B) elements (Jain et al.,
1995). We assessed the effect of Salp15 on the bindingTo further determine whether the lack of activation
could be due to specific inhibition of IL-2 production, activity of these transcription factors in CD4 T cells
that had been activated with anti-CD3/CD28 mAbs. AP-1we assessed the effect of exogenously added recombi-
nant IL-2 during activation. The proliferation of CD4 DNA binding activity was not affected by Salp15 (Figure
5A). However, NF-AT and NF-B DNA binding activitiesT cells activated in the presence of Salp15 increased
markedly with the addition of 10 ng/ml of recombinant were substantially reduced in CD4 T cells activated in
the presence of Salp15 (Figure 5A). As a control, wemurine IL-2 (rmIL-2) (Figure 3F). Furthermore, the ex-
pression of CD25 in the presence of Salp15 also in- also tested the DNA binding capacity of the cyclic AMP
response element binding protein (CREB), which wascreased to similar levels in the presence of recombinant
IL-2 (data not shown). Interestingly, a stronger inhibitory not affected by the presence of Salp15 (Figure 5A). In
agreement with these results, NF-AT transcriptional ac-effect of Salp15 on IL-2 production was observed at
lower concentrations of anti-CD3 mAb (Figure 4A) or tivity was compromised when CD4 T cells from NF-
AT-luciferase reporter transgenic mice were activatedwhen CD4 T cells were activated in the absence of
costimulation provided by anti-CD28 (Figure 4B). These in the presence of Salp15 (Figure 5B). Salp15 did not
induce AP-1 or NF-B-DNA binding activity in unstimu-data suggested that Salp15 was interfering with T cell
receptor (TCR) signals. lated cells (data not shown), indicating that it exerted
its effect through the inhibition of TCR-mediated tran-The initial production of IL-2 by CD4 T cells that
Immunity
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Figure 3. Salp15 Inhibits IL-2 Production and CD25 Expression of Anti-CD3/CD28 mAbs-Activated CD4 T Cells
(A and B) 106 purified naive CD4 T cells per ml were activated in vitro with plate-bound anti-CD3 mAb and soluble anti-CD28 mAb in the
presence of different concentrations of Salp15 for 44 hr (A) or 50 g per ml of Salp15 (open squares) during different time periods (B). At the
specified time points, IL-2 levels in the culture supernatants were measured by capture ELISA. Black squares represent controls without
Salp15.
(C) IL-2 mRNA was detected by RT-PCR in 16 hr stimulated CD4 T cells in the presence of anti-CD3/CD28 mAbs  50 g/ml of Salp15.
-actin was used as a control to ensure equal loads of RNA.
(D) 106 purified CD4 T cells were incubated with anti-CD3  anti-CD28 in the absence or presence of 50 g/ml of Salp15 or tick saliva (1/100
dilution)  rabbit Salp15 antisera (1/500 dilution). Normal rabbit sera (NRS) was used as a control. The supernatants were analyzed at 48 hr
of activation for IL-2.
(E) 106 purified CD4 T cells/ml were activated with anti-CD3/CD28 mAbs in the absence (thick line) or presence (thin line) of 50 g/ml of
Salp15. At 40 hr the cells were washed and stained for CD25 expression.
(F) 106 CD4 T cells/ml were activated with anti-CD3/CD28 mAbs in the presence of 50 g/ml of Salp15  exogenous recombinant murine
IL-2 (10 ng/ml). At 60 hr of activation, the cells were pulsed with [3H]thymidine for 18 hr.
scriptional activation. Together, these results suggested activation of CD4 T cells with anti-CD3 and anti-CD28
prevented Salp15-mediated inhibition of IL-2 productionthat Salp15 was interfering with early signals induced
by TCR crosslinking. (Figure 4E) without affecting the viability of these cells
(data not shown). These data imply that the inhibitoryWe hence assessed the effect of Salp15 on Ca2mobi-
lization in response to TCR signals by flow cytometry effect of Salp15 on CD4 T cells is predominantly due
to the inhibition of TCR-mediated calcium mobilization.using the fluorophore Indo-1. While anti-CD3 mAb
caused a rapid increase of intracellular calcium levels,
the presence of Salp15 delayed and reduced the Ca2 Salp15 Inhibits CD4 T Cell Activation In Vivo
Activation of naive CD4 T cells requires a rise in IL-2flux induced by TCR ligation (Figure 5C). To determine
whether the effect of Salp15 on Ca2 mobilization was production, whereas the activation of effector CD4 T
cells is less dependent on this cytokine (Yasui et al.,the cause of the inhibition in IL-2 production by the
protein, we examined IL-2 production by CD4 T cells 1998). To determine whether Salp15 inhibited the activa-
tion of effector CD4 T cells, we performed restimulationactivated with PMA and ionomycin. The levels of IL-2
produced by CD4 T cells were equivalent in the ab- assays with CD4 T cells that had been differentiated
in vitro for 4 days and from immunized mice. In vitro-sence or the presence of Salp15 (Figure 5D). Moreover,
the addition of low doses of ionomycin (50 ng/ml) during generated effector CD4 T cells produced similar levels
Immunosuppression Mediated by Salp15
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Figure 4. Salp15 Inhibits Early TCR-Mediated Signals
(A) 106 naive CD4 T cells per ml were activated with different concentrations of anti-CD3 mAb plus 1 g/ml of anti-CD28 mAb for 44 hr in
the presence of 20 g of Salp15 per ml (open squares) or without Salp15 (black squares).
(B) 106 CD4 T cells per ml were activated with plate-bound anti-CD3 (5 g/ml) in the absence of costimulation and in the presence of different
concentrations of Salp15. The supernatants were analyzed for IL-2 after 24 hr. As a control, purified CD4 T cells were incubated in the same
conditions in the presence of anti-CD28 (1 g/ml)  50 g/ml of Salp15 (control).
(C) Purified CD4 T cells (106 cells/ml) were activated with anti-CD3/CD28. At different time points (0, 12, 20, and 40 hr), 50 g/ml of Salp15
was added to the cultures. The supernatants were recovered at 72 hr and analyzed for IL-2. The results shown are representative of two to
four individual experiments.
of IL-2, IFN, and IL-4 in response to anti-CD3 in the protein, we immunized mice with keyhole limpet hemo-
cyanin in the absence or presence of 50 g of Salp15absence or presence of Salp15 produced in the Dro-
sophila expression system (Figure 6A). Similarly, Salp15 produced in Drosophila cells. The levels of KLH-specific
IgG antibodies in the sera of the mice that had beendid not affect the proliferative capacity of restimulated
effector cells (Figure 6B). For these experiments, we injected with Salp15 were significantly lower than in
control animals (Figure 7A, p  0.05). These data are inalso cloned and expressed Salp15 as a fused partner
to thioredoxin (TR) (Figure 6C) to specifically assess the agreement with reports describing absent IgG re-
sponses in Balb/c mice after repeated exposures to tickeffect of the immunomodulatory protein on CD4 T cell
activation and T cell-mediated antibody production in feeding (Christe et al., 1998). Furthermore, delayed-type
hypersensitivity reactions elicited by KLH administrationvivo. CD4 T cells from TR-immunized animals re-
sponded similarly to TR, and TR fused to Salp15 (TR- were also impaired in mice that had been immunized
with the protein in the presence of Salp15 at 24 hr (FigureSalp15) and produced high levels of IFN- (Figure 6D),
suggesting that the stimulation of effector CD4 T cells 7B) and 48 hr postchallenge (not shown). At both time
points, the difference in ear swelling between KLH	 andwas not affected by the presence of Salp15. However,
CD4T cells from TR-Salp15-immunized mice produced KLH Salp15-immunized mice were statistically signifi-
cant (Student’s t test, p 
 0.0017 at 24 hr; p 
 0.0013lower levels of IFN in response to both TR and TR-
Salp15 (Figure 6D), indicating that the presence of at 48 hr). The impaired development of a strong IgG
antibody and DTH responses in the presence of Salp15Salp15 inhibited the activation of antigen-specific CD4
T cells in vivo. IL-4 production was below detectable reinforced the idea of an inhibitory effect of the protein
on CD4 T cell activation.levels in all cases (data not shown).
CD4 T cells are an important factor in the develop-
ment of humoral antibody responses (Stavnezer, 1996). Discussion
Therefore, we determined whether the inhibitory effect
of Salp15 on CD4 T cells influenced the generation of Tick saliva is abundantly secreted into the host during
feeding (reviewed by Wang and Nuttall, 1999) and con-the murine antibody response. We found no difference
in TR-specific IgM levels in the sera from TR- and TR- tains anticoagulant, vasodilatory, and immunosuppres-
sive activities (Ribeiro et al., 1985, 1995; Urioste et al.,Salp15-immunized mice, indicating that T-independent
B cell responses had not been affected by the presence 1994; Valenzuela et al., 2000; Wikel, 1996). The interac-
tion between arthropods and their hosts is a dynamicof Salp15 (Figure 6D). Furthermore, Salp15 did not affect
LPS-induced B cell proliferation (data not shown), process and the result of coevolution (Wang and Nuttall,
1999). Upon attachment of the vector, the host elicitsagreeing with previous reports indicating that tick infes-
tation does not affect, or slightly increases, B cell re- both specific and nonspecific immune responses to the
vector. In turn, ticks have developed adaptive mecha-sponses to LPS (Ganapamo et al., 1996). Similarly,
Salp15 did not influence Borrelia burgdorferi-induced nisms to modulate the host immune response (Ferreira
and Silva, 1999; Wikel, 1999). The equilibrium betweenTNF production by CD11c cells (data not shown). In
contrast, TR-specific IgG antibody levels were signifi- the host immune responses and the vector’s immuno-
suppressive countermeasures partially determines thecantly reduced in the sera obtained from mice immu-
nized in the presence of Salp15 (TR-Salp15), compared duration of attachment, the degree of engorgement, and
the extent of pathogen transmission (Wikel and Berg-to control immunized mice (Figure 6E). To ensure that
Salp15 had not influenced the antigenicity of the fusion man, 1997; Zeidner et al., 1996). In this study, we have
Immunity
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Figure 5. The Immunosuppressive Activity of Salp15 Is Mediated through the Inhibition of Calcium Mobilization and IL-2 Production
(A) Salp15 inhibits NF-B and NF-AT DNA binding activity. Nuclear extracts were obtained from activated CD4 T cells (106 cells/ml) in the
presence () or absence (	) of 50 g/ml of Salp15. Electromobility shift analysis was then performed using specific 32P end-labeled double-
stranded oligonucleotides representing the consensus binding sites for AP-1, NF-AT, NF-B, and CREB (control).
(B) Purified CD4 T cells from NF-AT-luciferase reporter transgenic mice were activated with anti-CD3/CD8 in the presence of 50 g/ml of
Salp15 (open symbols) or without Salp15 (closed squares) and analyzed for luciferase activity at 48 and 60 hr of activation.
(C) Salp15 inhibits calcium mobilization in response to TCR signals. CD4 T cells were loaded with Indo-1 for 45 min. The ratio of bound
Indo-1 fluorescence (395 nm) to unbound Indo-1 fluorescence (525 nm) was determined for baseline during preincubation with Salp15 (100
g/ml), after anti-CD3 plus anti-hamster IgG treatment (40 and 60 g/ml, respectively), and after ionomycin induction (500 ng/ml). Phosphate-
buffered saline (PBS) was used as a control.
(D and E) Salp15 does not inhibit IL-2 production by CD4 T cells stimulated with PMA  ionomycin. 106 CD4 T cells/ml were activated in
the presence of (D) PMA (5 ng/ml)  ionomycin (250 ng/ml) or (E) anti-CD3/CD28 mAbs  50 ng/ml ionomycin in the absence or presence of
50 g/ml of Salp15. The results are representative of two to four experiments.
characterized a 15 kDa I. scapularis saliva protein, of anti-CD28 or in the absence of costimulation, which
provides an increase of the signal delivered through theSalp15, that inhibits CD4 T cell activation.
Our results show that Salp15 has an inhibitory effect TCR (Michel et al., 2001). Furthermore, differences in the
activity between native tick saliva and the recombinanton CD4 T cells in vitro and in vivo. IL-2 production,
upregulation of the  chain of the IL-2 receptor, and protein produced in vitro may be due to the degree of
appropriate folding in the recombinant protein. Theseconsequent proliferation are all readouts of CD4 T cell
activation (Theze et al., 1996). Salp15 inhibited all three alterations may not, however, influence binding capacity
to the cell surface. These data strongly suggest that,in a dose-dependent fashion without exerting a toxic
effect on CD4 T cells. Moreover, the addition of exoge- under physiological conditions, Salp15 is likely to induce
high levels of inhibition, even though it represents 0.1%nous IL-2 prevented the Salp15-mediated inhibition of
CD4 T cell activation, indicating that the inhibitory ef- of the total protein content of tick saliva (1 mg/ml, which
corresponds to a concentration of 1 g/ml of Salp15,fect of Salp15 is due to repression of IL-2 production
and not due to toxic effects or interference with the data not shown).
Crosslinking of TCR complexes and CD28 moleculesresponse of CD4 T cells to IL-2.
Our results strongly suggest a quantitative effect of on naive T cells induces multiple intracellular signaling
pathways that lead to the activation of specific nuclearSalp15 that depends on the strength of the signal deliv-
ered through the TCR. Supporting this assertion, we transcription factors, including AP-1, NF-AT, and NF-
B. IL-2 is a key cytokine gene regulated by these tran-have demonstrated that Salp15 activity is greatly in-
creased when lower concentrations of anti-CD3 anti- scription factors (Jain et al., 1995). Our data demonstrate
that Salp15 inhibits IL-2 production upon TCR engage-body are used to activate CD4 T cells in the presence
Immunosuppression Mediated by Salp15
855
Figure 6. Salp15 Inhibits CD4 T Cell Activation In Vivo
(A and B) In vitro-generated effector cells were activated for 24 hr with anti-CD3 in the absence (black bars) or presence (white bars) of Salp15
produced in Drosophila cells. The supernatants were collected after 24 hr and analyzed for IL-2, IL-4, and IFN by capture ELISA (A) and
proliferation (B).
(C) Purified TR (1) and TR-Salp15 (2).
(D) Balb/c mice were immunized with equimolar quantities of TR or TR-Salp15 (equivalent to 10 g of TR-Salp15). Eleven days later, CD4 T
cells were purified and analyzed in recall responses to TR and TR-Salp15. IFN levels were measured in 40 hr restimulation supernatants.
(E) TR-specific IgM (1/160 dilution) and IgG (1/320 dilution) levels in the sera of the TR- (black bars) and TR-Salp15-immunized mice (white
bars) were determined by ELISA using TR-bound plates. Experiments were repeated three times.
ment by repressing calcium signals that result in de- of CD4 T cells is due to impaired TCR signaling, re-
sulting in the inhibition of transcription of the IL-2 gene.creased DNA binding activity of NF-AT and NF-B. The
effect of Salp15 on IL-2 production could be prevented Because of the potential immunosuppressive effect of
the saliva protein in vivo, we tested whether the immuneby the activation of CD4 T cells with PMA plus iono-
mycin or the addition of ionomycin during activation of response against a foreign antigen was affected by the
presence of Salp15. Our data suggest that the inhibitoryCD4 T cells with anti-CD3/CD28. These data indicate
that the inhibitory effect of Salp15 on IL-2 production effect of Salp15 on TCR-mediated CD4 T cell activation
Figure 7. Salp15 Inhibits DTH Induced by
KLH
(A) Groups of five mice were immunized with
1 g of KLH in the absence (black bar) or
presence (white bar) of 10 g of Drosophila-
produced Salp15 in CFA. The animals were
boosted after 2 weeks, and 10 days later their
sera were analyzed for KLH-specific IgG anti-
bodies by ELISA.
(B) Groups of four mice were immunized with
KLH in the absence or presence of Salp15.
Animals immunized with Salp15 alone served
as controls. Four days later the mice were
challenged with KLH in the ears. Ear swelling
was recorded at 24 and 48 hr after challenge.
Results indicate increase in ear thickness at
24 hr postchallenge compared to time 0 (prior
to immunization).
Immunity
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has an effect on the murine immune response in vivo. environment. Therefore, delineating the mechanisms
Interestingly, Schoeler and colleagues (1999) showed that ticks use to influence host immune responses may
that T lymphocytes from Balb/c mice repeatedly infested lead to an understanding of competency of the vector
with I. scapularis nymphs in vivo do not produce high for specific hosts, the prevention of arthropod-borne
levels of IFN in response to ConA restimulation ex vivo. diseases, and the characterization of new molecules
We suggest that the inhibitory effect of Salp15 on IL-2 that can be used as anti-inflammatory or immunosup-
production affects the activation of naive CD4 T cells pressive agents.
in vivo and their differentiation to immune effector cells.
Experimental ProceduresOn the other hand, CD4 T effector cells were not inhib-
ited when incubated with Salp15, probably because
Purification of Salp15these cells are less dependent on IL-2 and do not or
salp15 was amplified from a pBluescript vector using specific prim-hardly produce this cytokine in response to antigen stim- ers: 5-GAAAGCGGCCCAACTAAA-3 and 5-CTAACATCCGGGA
ulation (Mannie et al., 1996). Most interestingly, TR-spe- ATGTG-3. The PCR product was subcloned into the pMT/BiP/V5-
cific IgG but not IgM antibody responses were dimin- His A vector (Invitrogen, Carlsbad, CA) and transfected into Dro-
sophila S2 cells (Invitrogen) in combination with the hygromycinished in mice immunized with Salp15. IgM antibodies
selection vector pCOHYGRO for stable transfection. The stableare produced by B lymphocytes, whereas switching to
transformants were selected using 300 g/ml hygromycin-B for 3–4IgG subclasses is dependent on CD4T cell cooperation
weeks. The resistant cells were grown as large spinner cultures,(Stavnezer, 1996). Indeed, Ganapamo and colleagues
switched to DES serum-free medium for 2 days, and induced with
(1996) reported that tick infestation does not affect, or copper sulfate to a final concentration of 500 M for 4 days. The
slightly increases, B cell responses to LPS. Consistent cells were then centrifuged at 1000 g for 5 min. The supernatant
with these results, Salp15 did not exert any effect on was used to purify the protein using the Talon metal affinity resin
(Clontech, Palo Alto, CA). The protein was eluted using 100 mMLPS-induced B cell proliferation.
imidazole, extensively dialyzed against PBS (pH 7.8), and concen-The results presented here argue against a relation-
trated by centrifugal filtration through a 10 kDa filter (Millipore Corp.,ship between Salp15 and the potential IL-2 binding pro-
Bedford, MA). The PCR product was also subcloned into the pBAD/
tein activity described by Gillespie and colleagues Thio-TOPO vector (Stratagene, La Jolla, CA) and transformed into
(2001). First, the effects elicited by Salp15 on CD4 T TOP 10 Escherichia coli cells (Invitrogen). The protein, fused to
cells occur very early during the activation process, be- thioredoxin (TR), was then induced with 2% arabinose and purified
using Ni2 columns, following the manufacturer’s specifications (In-fore IL-2 is produced by T cells. Second, the temporal
vitrogen). The poli-His tagged fusion protein was eluted with imidaz-frame of Salp15 activity as an immunosuppressor is
ole, dialyzed, and concentrated. TR control protein was expressedlimited, since the addition of Salp15 at 40 hr of activation
and purified in an identical fashion. The purity of the proteins wasdoes not affect the completion of the activation process,
checked on SDS-PAGE.
indicating that Salp15 does not influence IL-2–IL-2 re-
ceptor interactions. Third, Salp15 acts by interfering with Immunohistochemistry
TCR-mediated signaling events. Overall, our data indi- Female Balb/c mice were challenged with 15 nymphal ticks on the
cate that Salp15 acts early during the activation process back. Two days after tick detachment, skin punch biopsies of 4–5
mm were obtained at the site of tick attachment in the experimentalby interfering with TCR-mediated signals that lead to
animals. The biopsies were embedded in Optimun Cutting Tempera-IL-2 production. The activity is eliminated when the lev-
ture (O.C.T.) compound (Sakura Finetek, U.S.A., Inc., Torrance, CA)els of IL-2 and the increase of surface CD25 allow for
and quick frozen in a dry ice-ethanol bath. Skin biopsies from naive
a continuation of the activation process that is less de- mice were also obtained and frozen in O.C.T compound to serve
pendent on TCR stimulation (Bajenoff et al., 2002). Tick as negative controls. Frozen O.C.T.-embedded skin specimens were
saliva contains multiple activities that can influence cut into 4 m thick serial sections in a cryostat, collected on Su-
CD4 T and other cell type activation and effector func- perfrost Plus glass slides (Gallard-Schlesinger Industries, Garden
City, NY), and fixed with cold acetone for 20 min. Sections weretions. These include the inhibition of IFN production
allowed to air dry and were incubated with Tris-buffered saline (TBS)by differentiating T cells in saliva of I. ricinus (Leboulle
for 5 min. Endogenous peroxidase activity was blocked by incuba-et al., 2002). Our data indicate that Salp15 has no effect
tion with 3% H2O2 for 5 min at room temperature. Sections wereon the commitment of these cells. Therefore, we can rinsed with double distilled water (ddH2O), followed by TBS for an-
conclude that the overall activity of tick saliva on the other 5 min, and then blocked with blocking buffer (5% normal goat
immune system relies on the participation of several serum and 1% triton-X 100 in TBS) at room temperature for 30 min.
After the blocking step, sections were incubated overnight withcomponents, including Salp15.
Salp15 antisera (1:500 dilution). Normal rabbit sera were used asSalp15 is the first I. scapularis protein associated with
control. After three washes with TBS, the sections were incubatedthe immunosuppressive activity of tick saliva. Our data
with anti peroxidase-conjugated anti-rabbit IgG (1:500 dilution) atimply that the inhibitory effect of Salp15 on TCR-medi-
37C for 30 min. Sections were washed with TBS followed by ddH20ated activation of naive CD4 T cells results in de- twice. The slides were developed with diaminobenzidine (Sigma
creased numbers of responding immune effector cells. Chemical Co., St. Louis, MO). The sections were rinsed in running
Immune modulation is probably most important for the water and mounted with Crystal/Mount (Biomed Corp. City State),
followed by addition of a coverslip. The sections were then visual-vector at the site of the tick bite, since the responses
ized under a light microscope.that the arthropod encounters during feeding occur lo-
cally. The inhibition of acquired immune responses may
Binding Assaysalso be ecologically significant, helping to ensure that
Salp15 was equilibrated in carbonate buffer (pH 9.5) and labeledthe host remains susceptible to future tick infestations.
with fluorescein isothiocyanate (20 g per mg of protein) for 2 hr at
Moreover, microorganisms that rely on vectors to com- RT. Unbound fluorescein was then eliminated by size exclusion
plete their natural life cycle may take advantage of these chromatography. The labeled protein was then buffer exchanged
immunomodulatory strategies to promote their survival to a Tris-based buffer (Tris-HCl 50 mM and NaCl 150 mM [pH 7.0]).
107 per ml purified CD4 T cells were preincubated with 10 mg/mlin the mammalian host and their adaptation to their new
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of BSA for 10 min, incubated with Salp15FITC for 30 min, washed, stranded oligonucleotides representing the consensus binding sites
for AP-1, NF-AT, NF-B, and CREB (control) (Schreiber et al., 1989).and analyzed by flow cytometry using a FACScalibur apparatus and
the CellQuest software package (Becton Dickinson, Mountain View, The oligonucleotides used are as follows (sense strand): IL2-NF-AT,
5-GCCCAAAGAGGAAAATTTGTTTCATACAG-3; AP-1, 5-GTCGACA). Negative controls were incubated in the same fashion with
BSAFITC (30 g per 106 cells). CD4 T cell membrane fractions were CGTGAGTCAGCGCGC-3 (Rinco´n and Flavell, 1997); NF-B, 5-
GATCAGAGGGGACTTTCCGAG-3 (Millet et al., 2000); and CREB,obtained by passage of purified CD4 T cells through a nitrogen
bomb at 1000 psi. The membrane fraction was then collected by 5-AGAGATTGCCTGACGTCAGAGAGCTAG-3.
centrifugation, and the protein content was measured using the
Bradford method. Complete cell disruption was assessed visually Intracellular Calcium Levels
under the microscope. Four hundred nanograms of protein-con- 106 CD4 T cells were loaded with 7 M Indo-1 for 45 min. Ten
taining membrane fractions were coated in 96-well plates in bicar- minutes before the assay, 2-aminoethoxydiphenyl borate (2-APB,
bonate buffer (pH 9.6) overnight at 4C, blocked with PBS plus 10% 20 M, a gift from M. Nelson) was added. The cells were then
FCS, and preincubated with PBS or trypsin (20 g/ml) for 1 hr, transferred to a Standard Extracellular Solution (in mM: 140 NaCl,
followed by extensive washing. The wells were incubated for 1 hr 4 KCl, 1 CaCl2, 2 MgCl2, 1 KH2PO4, 10 glucose, and 10 HEPES, [pH
with 30 g/ml of soybean trypsin inhibitor and washed. Salp15 was 7.4]). The ratio of bound Indo-1 fluorescence (395 nm) to unbound
then added at different concentrations in PBS  10% FCS followed Indo-1 fluorescence (525 nm) was then determined for baseline,
by incubation with rabbit Salp15 antisera and a biotinylated anti- during preincubation with Salp15 (100 g/ml), after anti-CD3 plus
rabbit IgG and streptavidin bound to HRP. Salp15 antisera was anti-hamster IgG treatment (40 and 60 g/ml, respectively), and
prepared by immunizing a rabbit with 100 g of recombinant Salp15 after ionomycin induction (500 ng/ml).
produced in the Drosophila expression system in complete Freund’s
adjuvant and boosting the animal with 100 g of Salp15 in incom- Immunizations and DTH Reactions
plete Freund’s adjuvant at 2 and 4 weeks. The assay was developed Groups of four Balb/c mice were immunized with equimolar quanti-
with TMB substrate and stopped with TMB 1 component stop solu- ties (0.5 M, corresponding to 50 g of TR-Salp15) of TR or TR-
tion. The wells were read at 450 nm. Salp15 in complete Freund’s adjuvant (CFA). Eleven days later, CD4
T cells were purified and analyzed in recall responses to TR and
Tick Saliva Collection and Determination of Salp15 Concentration TR-Salp15. IFN- levels were measured by capture ELISA in 40 hr
Adult ticks were allowed to feed on the backs of guinea pigs for 3 restimulation supernatants (Anguita et al., 1996). TR-specific IgM
days and were removed mechanically. The ticks were then immobi- (1/160 dilution) and IgG (1/320 dilution) levels in the sera of the
lized, and a finely drawn capillary tube was fitted over their mouth- immunized mice were determined by ELISA (Anguita et al., 1996)
parts. Two to five microliters of 5% pilocarpine (Sigma Chemical using TR-bound plates. In another set of experiments, groups of
Co.) in methanol was applied topically to their dorsa, and saliva was five mice were immunized with 1 g of KLH in the absence or
collected over periods of 1–2 hr, pooled, and stored at 	70C until presence of 10 g of Salp15. The mice were boosted with KLH 
use. The concentration of total protein present in tick saliva was Salp15 after 10 days in incomplete Freund’s adjuvant (IFA). Ten
determined by the Bradford method (Bio-Rad). The concentration days later, KLH-specific IgG levels in the sera were measured by
of Salp15 in saliva was estimated by Western blot analysis using capture ELISA, as before.
rabbit antisera and known concentrations of recombinant Salp15 Delayed-type hypersensitivity reactions were performed as fol-
produced in the Drosophila expression system as standards. lows. Groups of four mice were immunized with 10 g of KLH in
the absence or presence of 50 g of Salp15. Control animals were
injected with 50 g of Salp15 without KLH. Four days later, all miceCD4 T Cell Purification and Activation
were challenged in both ears with 1 g of KLH. Ear swelling wasCD4 T cells from naive or immunized mice were purified by negative
recorded at 24 and 48 hr after challenge. The difference betweenselection as described (Anguita et al., 2001). 106 CD4 T cells per
ear thickness before immunization and after challenge was recordedml were activated with plate-bound anti-CD3 (5g/ml, except where
and tabulated for each mouse.indicated) plus soluble anti-CD28 (1 g/ml). At the specified time
points, the supernatants were collected and analyzed for cytokines
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